Press release
Growth Spikes in the Global Companion Diagnostics Market: Evaluated at $7.34 Billion in 2025, Globally Projected to Reach $19.07 Billion by 2029
Companion Diagnostics Market Size
Exponential Growth Expected in the Companion Diagnostics Market Spanning the Next Few Years, with Developing Trends and Key Market Players
What is the Projected Market Size of the Global Companion Diagnostics Market and Its Growth Rate?
The companion diagnostics market is witnessing substantial growth in the recent years. The key statistics include:
• The market size of $7.34 billion in 2024
• Growth to $8.75 billion in 2025 with a CAGR of 19.3%
• The market to reach $19.07 billion in 2029 at a CAGR of 21.5%
The factors leading to historic growth are increased adoption of personalized medicine, expansion in oncology and cancer therapies, increased pharmaceutical R&D collaboration, precision medicine initiatives, and biomarker discovery. The forecast growth can be attributed to targeted therapy development, evolution of infectious disease diagnostics, increase in rare disease diagnostics, rise of biomarker-based drug development, advent of point-of-care testing, and applications of liquid biopsy.
What is Driving the Growth in the Companion Diagnostics Market?
The increasing number of targeted therapies are a significant factor expected to propel the growth of the companion diagnostics market. Targeted therapy, a pharmacological therapy specifically targeting certain characteristics of cancer cells to inhibit their growth and spread, has been gaining traction. The therapy circulates throughout the body, providing a more targeted effect with often fewer adverse effects than traditional chemotherapy. The surge in targeted therapies, therefore, drives the growth in the companion diagnostics market.
Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=7038&type=smp
Who Are the Key Players Driving Companion Diagnostics Market Growth?
The companion diagnostics market is characterised by several major companies, including:
• F Hoffmann-La Roche Ltd.
• Agilent Technologies Inc.
• Qiagen NV
• Thermo Fisher Scientific Inc.
• Abbott Laboratories Inc.
• Biomerieux SA
• Danaher Corporation
• Illumina Inc.
• Siemens Healthcare GmbH
• Bayer AG
What Are The Key Trends In The Companion Diagnostics Market?
Key trends in the forecast period include:
• Advances in immunotherapy and immunology
• AI and machine learning applications in diagnostics
• Novel product innovations
• Adoption of industry 4.0
• Strategic collaborations
What Are The Segments Of The Global Companion Diagnostics Market?
The market for companion diagnostics is segmented by:
• Product and Service: Assays, Kits and Reagents, Software, and Services
• Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry
• Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma
• End-User: Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations
Which Region Leads The Companion Diagnostics Market?
North America was the largest region in the companion diagnostics market in 2024. The report also examines other regions including Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East and Africa.
Pre-book the report for swift delivery: https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report
What Is Covered In The Companion Diagnostics Market Global Market Report?
- Market Size Analysis: Analyze the Companion Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Companion Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Companion Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Companion Diagnostics Market .
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report: https://www.thebusinessresearchcompany.com/Customise?id=7038&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
"Learn More About The Business Research Company
With over 15,000+ reports covering 27 industries across 60+ geographies, The Business Research Company provides comprehensive, data-rich research and insights. With 1,500,000 datasets, we contribute in-depth secondary research and unique insights from industry leaders to provide the information you need to stay ahead. Our flagship product, the Global Market Model, is a leading market intelligence platform providing comprehensive and up-to-date forecasts to support informed decision-making."
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growth Spikes in the Global Companion Diagnostics Market: Evaluated at $7.34 Billion in 2025, Globally Projected to Reach $19.07 Billion by 2029 here
News-ID: 3812492 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Companion
Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook…
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74…
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors.
The Artificial Intelligence (AI) In Beauty and Cosmetics Market…
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673
This latest report researches the industry structure, sales, revenue,…
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S.
Moreover, the…
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test…
